Unizima
Unizima is a biomanufacturing services and technology provider embedded within the global health space, focused on providing technical, strategic, and workforce services for the biomanufacturing sector. As part of the Univercells Group, it aims to enable sustainable production of biologics such as vaccines, monoclonal antibodies, and insulin in emerging markets, with a mission to make biologics accessible to all. The company collaborates with governments, global health organizations, and biopharma manufacturers to build local bioproduction capabilities, support workforce development, and promote innovative manufacturing solutions to improve global health equity.
Industries
Nr. of Employees
medium (51-250)
Unizima
Zoning de Jumet, Allée centrale 52, 6040 Jumet, Belgium
Products
Fill & Finish costing simulation tool
A financial and costing simulation tool to evaluate CapEx/Opex, utilisation and profitability for regional fill & finish contract manufacturing projects.
Pre‑designed modular facility templates
Customizable modular facility designs and specifications for rapid deployment of biomanufacturing capacity (pre‑qualified modules for various production scales).
Fill & Finish costing simulation tool
A financial and costing simulation tool to evaluate CapEx/Opex, utilisation and profitability for regional fill & finish contract manufacturing projects.
Pre‑designed modular facility templates
Customizable modular facility designs and specifications for rapid deployment of biomanufacturing capacity (pre‑qualified modules for various production scales).
Services
Objective technical and strategic advice covering product selection, market analysis, regulatory pathway, and investment feasibility for governments, funders and manufacturers.
End‑to‑end design, engineering, construction oversight and CQV of new or upgraded biologics manufacturing sites, including modular facility deployments.
Recruitment, organisational design, bespoke on‑the‑job upskilling, training curriculum development, train‑the‑trainer programs and coordination of academic internship placements.
Investment project management, tendering support, procurement strategy and client user representation during audits and project follow‑up.
QMS design, GMP inspection readiness, registration support, GMP audits and remediation planning, and support for PPQ/validation activities.
Brokerage and management of public‑private partnerships, academic collaborations and donor engagements to enable training, tech transfer and co‑funded projects.
Objective technical and strategic advice covering product selection, market analysis, regulatory pathway, and investment feasibility for governments, funders and manufacturers.
End‑to‑end design, engineering, construction oversight and CQV of new or upgraded biologics manufacturing sites, including modular facility deployments.
Recruitment, organisational design, bespoke on‑the‑job upskilling, training curriculum development, train‑the‑trainer programs and coordination of academic internship placements.
Investment project management, tendering support, procurement strategy and client user representation during audits and project follow‑up.
QMS design, GMP inspection readiness, registration support, GMP audits and remediation planning, and support for PPQ/validation activities.
Brokerage and management of public‑private partnerships, academic collaborations and donor engagements to enable training, tech transfer and co‑funded projects.
Expertise Areas
- Biomanufacturing advisory and strategy
- Facility design, engineering and CQV
- Modular manufacturing and CDMO setup
- Process technology transfer and scale‑up
Key Technologies
- Modular biomanufacturing facilities
- Single‑use bioreactor systems
- Intensified/continuous bioreactors
- Blow‑Fill‑Seal (BFS) and alternative container systems
News & Updates
Unizima has joined a UK Government-backed initiative led by the Liverpool School of Tropical Medicine to strengthen the biotech landscape in Liverpool and its wider city region, with a focus on accelerating the transition from research to clinical applications and biotech innovation.
Unizima supports the establishment of MADIBA, a new world-class vaccine manufacturing facility in Senegal, which aims to produce up to 300 million doses per year, enhancing local vaccine autonomy and access.
Unizima announces new academic partnerships with universities in Senegal, Rwanda, and Belgium to create a joint Master's degree in biotechnology, supporting capacity building and local biotech expertise in Africa.
Unizima is involved in the MADIBA project in Senegal, supporting vaccine manufacturing and local bioproduction capacity development.
Unizima is providing technical support, project management, recruitment, and training for the MADIBA vaccine manufacturing project in Senegal.
Unizima has joined a UK Government-backed initiative led by the Liverpool School of Tropical Medicine to strengthen the biotech landscape in Liverpool and its wider city region, with a focus on accelerating the transition from research to clinical applications and biotech innovation.
Unizima supports the establishment of MADIBA, a new world-class vaccine manufacturing facility in Senegal, which aims to produce up to 300 million doses per year, enhancing local vaccine autonomy and access.
Unizima announces new academic partnerships with universities in Senegal, Rwanda, and Belgium to create a joint Master's degree in biotechnology, supporting capacity building and local biotech expertise in Africa.
Unizima is involved in the MADIBA project in Senegal, supporting vaccine manufacturing and local bioproduction capacity development.
Unizima is providing technical support, project management, recruitment, and training for the MADIBA vaccine manufacturing project in Senegal.